Dr. Nicole Soucy is the Director of Global Toxicology and Biocompatibility in the Preclinical Sciences Department at Boston Scientific. She has nearly 20 years of experience as a toxicologist and risk assessor for products regulated as medical devices, pharmaceuticals, and cosmetics. In her current role, Nicole built and now leads a team of 42 scientists to ensure all products developed and manufactured by Boston Scientific meet or exceed global regulatory requirements for the biological safety evaluation of medical devices - a key safety input for regulatory approval in all regions. In her prior role, Nicole provided technical support, leadership, and guidance to a team of scientists supporting 3M Health Care Business Group, a diverse group of businesses developing and commercializing active pharmaceutical ingredients, drug delivery systems, medical devices, combination products, and cosmetics.
Nicole received a PhD in pharmacology and toxicology from Dartmouth College in 2003, where her research investigated mechanisms for cardiovascular disease following exposure to metals and metalloids. This was followed by a post-doctoral fellowship at the Chemical Industry Institute of Toxicology (CIIT) where her research focus was on gestational pharmacokinetics of endocrine disrupting compounds. Nicole has been an active member of the Society of Toxicology since 2000; serving in leadership roles in the Northland Regional Chapter and participating as a member of the RC Collaboration and Communication Committee and former Education Committee. In 2022 Nicole was elected to a role on the SOT Nominating Committee. A Diplomate of the American Board of Toxicology since 2012, Nicole has served on the Board of Directors since 2019 where she is currently serving as President.
Nicole Soucy is mentoring Nader Abdalla.